CytomX's CX-2051, a PROBODY® EpCAM-targeted antibody-drug conjugate (ADC), showed a 28% confirmed response rate and 5.8-month ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

Grey’s Anatomy star Kate Walsh is partnering with GRAIL to advocate for more multi-cancer early detection testing in a ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...